There is not much to be said about today's announcement from Open Orphan (ORPH) announcement to extend its contracts with Carna Bioscience, Inc., other than to say this was not the announcement I was expecting this morning or anyone else in the investment community and offers assurance post-Brexit normal service has resumed with European partners and indeed the wider business community. I have asked the company's PR for comment, as yet, nothing. Anna is usually quite good or has been in the past, so I have some hope. Even so, I suspect we will learn more during the investor presentations on Wednesday.
IMHO Game-Changing news yet to be RNSed. https://t.co/Mtw0Si1TACThese test kits change the antigen testing landscape.These kits are CE marked with very high accuracy results in rapid time. pic.twitter.com/ydiTBsd3bC— Small Company Champion (@LEMMINGINVESTOR) January 30, 2021
I guess we can add the following Tweet to the above Tweet which offers further encouragement as well as raises more questions for Cathal on Wednesday.
The Tweet appears to be a Flucamp banner on the side of Whitechapel Hotel with 27 bedrooms and immediately opposite the existing 24-bed quarantine facility in East London. Could this be the 3rd facility!? Asks @Eskers1
Check out our recent project for @flucamp where we installed:— Surface Prints (@SurfacePrintsUK) February 1, 2021
▶︎ Printed boards
▶︎ Floor vinyl stickers
▶︎ Door stickers
▶︎ Lift, room & stair signage
▶︎ Social media printed posters
▶︎ Banner - required a 13m ladder 😅#FloorVinyl #SignageSolutions #DigitalPrinting pic.twitter.com/ZryvK9NYqN